007: Quality Data For FDA Submissions With Dr. Robert Hariri
Business Of Biotech
00:00
The FDA's Review of COVID-19 Potential Therapeutics
FDA is entertaining several therapies and vaccines due to address COVID-19 right now accelerating many of those approaches. FDA has tremendous experience in looking at various cell therapy candidates including placental cells we have we have um had many many problems with our TMPs. doing that applied to the FDA for a clinical study to demonstrate safety and efficacy and that's where we are today.
Play episode from 09:07
Transcript
